Cargando…
Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba
Individuals with cancer are vulnerable to infection with SARS-CoV-2, the virus causing COVID-19. Physical distancing, the reallocation of health care resources, and the implementation of procedures to reduce the spread of COVID-19 may also have serious consequences for people with cancer. We evaluat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395519/ https://www.ncbi.nlm.nih.gov/pubmed/34436035 http://dx.doi.org/10.3390/curroncol28040269 |
_version_ | 1783744192013402112 |
---|---|
author | Decker, Kathleen M. Lambert, Pascal Feely, Allison Bucher, Oliver Kim, Julian O. Hebbard, Pamela Thiessen, Maclean Fatoye, Tunji Pitz, Marshall Koul, Rashmi Czaykowski, Piotr |
author_facet | Decker, Kathleen M. Lambert, Pascal Feely, Allison Bucher, Oliver Kim, Julian O. Hebbard, Pamela Thiessen, Maclean Fatoye, Tunji Pitz, Marshall Koul, Rashmi Czaykowski, Piotr |
author_sort | Decker, Kathleen M. |
collection | PubMed |
description | Individuals with cancer are vulnerable to infection with SARS-CoV-2, the virus causing COVID-19. Physical distancing, the reallocation of health care resources, and the implementation of procedures to reduce the spread of COVID-19 may also have serious consequences for people with cancer. We evaluated the impact of COVID-19 on new cancer diagnoses and oncology care in Manitoba, Canada using an interrupted time series design and data from the Manitoba Cancer Registry and CancerCare Manitoba’s (CCMB) electronic medical record. In April 2020, there was a 23% decrease in new cancer diagnoses, a 21% decrease in pathology reports, and a 43% reduction in surgical resections. There was no difference in new cancer diagnoses by August 2020, surgery by July 2020, and pathology reports by September 2020. From April 2020 to June 2021, there was a 13% decrease in radiotherapy (RT) fractions, an 18% decrease in UCC visits, and a 52% decrease in in-person visits. There was no change in intravenous chemotherapy visits per month, first RT visits, or overall patient visits. The impact of COVID-19 on shifts in the stage at diagnosis and survival will be assessed in future analyses. |
format | Online Article Text |
id | pubmed-8395519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83955192021-08-28 Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba Decker, Kathleen M. Lambert, Pascal Feely, Allison Bucher, Oliver Kim, Julian O. Hebbard, Pamela Thiessen, Maclean Fatoye, Tunji Pitz, Marshall Koul, Rashmi Czaykowski, Piotr Curr Oncol Article Individuals with cancer are vulnerable to infection with SARS-CoV-2, the virus causing COVID-19. Physical distancing, the reallocation of health care resources, and the implementation of procedures to reduce the spread of COVID-19 may also have serious consequences for people with cancer. We evaluated the impact of COVID-19 on new cancer diagnoses and oncology care in Manitoba, Canada using an interrupted time series design and data from the Manitoba Cancer Registry and CancerCare Manitoba’s (CCMB) electronic medical record. In April 2020, there was a 23% decrease in new cancer diagnoses, a 21% decrease in pathology reports, and a 43% reduction in surgical resections. There was no difference in new cancer diagnoses by August 2020, surgery by July 2020, and pathology reports by September 2020. From April 2020 to June 2021, there was a 13% decrease in radiotherapy (RT) fractions, an 18% decrease in UCC visits, and a 52% decrease in in-person visits. There was no change in intravenous chemotherapy visits per month, first RT visits, or overall patient visits. The impact of COVID-19 on shifts in the stage at diagnosis and survival will be assessed in future analyses. MDPI 2021-08-12 /pmc/articles/PMC8395519/ /pubmed/34436035 http://dx.doi.org/10.3390/curroncol28040269 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Decker, Kathleen M. Lambert, Pascal Feely, Allison Bucher, Oliver Kim, Julian O. Hebbard, Pamela Thiessen, Maclean Fatoye, Tunji Pitz, Marshall Koul, Rashmi Czaykowski, Piotr Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba |
title | Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba |
title_full | Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba |
title_fullStr | Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba |
title_full_unstemmed | Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba |
title_short | Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba |
title_sort | evaluating the impact of the covid-19 pandemic on new cancer diagnoses and oncology care in manitoba |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395519/ https://www.ncbi.nlm.nih.gov/pubmed/34436035 http://dx.doi.org/10.3390/curroncol28040269 |
work_keys_str_mv | AT deckerkathleenm evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba AT lambertpascal evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba AT feelyallison evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba AT bucheroliver evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba AT kimjuliano evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba AT hebbardpamela evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba AT thiessenmaclean evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba AT fatoyetunji evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba AT pitzmarshall evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba AT koulrashmi evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba AT czaykowskipiotr evaluatingtheimpactofthecovid19pandemiconnewcancerdiagnosesandoncologycareinmanitoba |